TGFB1 and acute myeloid leukemia: The AML microenvironment contains high levels of immunosuppressive cytokines (such as TGF-β), regulatory cells (Tregs and MDSCs), and immune checkpoints (such as the PD-1/PD-L1 axis), all of which can inactivate T cells [42].